Progen shot itself in the foot when disgraced CEO Justus Homberg and his team initially fired all their principal research scientists in QLD and backstabbed investors by pulling PI-88. What irritated investors is this was not based on scientific reasons i.e. PI-88 performed well in clinical trials but because of poorly argued and unsubstantiated logistical reasons. This is nicely summarised in the link below.
http://www.canberratimes.com.au/news/local/news/general/drug-companies-must-be-forced-to-help-the-public/1387168.aspx
Progen was forced to return money back to investors who wanted to see PI-88 registered via a share buyback. Homberg also lost the company millions through a failed buy into Avexa (AVX).
Progen now has a new CEO (Sue Macleman) and appear to be in a sound cash position. They have control/ or soon will have control of PI-88 again and look to be getting back into phase three clinical trials and registration. They also seem to be looking to expand their IP portfolio.
Lets hope they can stay on track this time.
- Forums
- ASX - By Stock
- PGL
- can progen turn over a new leaf?
can progen turn over a new leaf?
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
|
|||||
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.30M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 44.5¢ | $25.84K | 58.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 373230 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 217306 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 373230 | 0.445 |
7 | 911759 | 0.440 |
3 | 8500 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 217306 | 9 |
0.460 | 100000 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
0.590 | 292887 | 2 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |